Millions of people are turning to cannabis to treat a range of health problems. But selecting the right strain is a roll of the dice. This is because we still know very little about the therapeutic effects of the roughly 500 Active Pharmaceutical Ingredients including cannabinoids, terpenes, flavonoids, and more. The science simply hasn’t been done to understand how they interact with the human body.
Opportune-Tx is changing this. Opportune-Tx predicts how different cannabis plant compounds interact with the human body to treat specific health problems. And they do it faster, more affordably, and more accurately than traditional solutions.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 1200 Boul Saint-Martin, Laval,quebec H7s 2e4,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- opportune-tx.ca
- HQ
- Laval, Quebec
Opportune Therapeutics Questions
Opportune Therapeutics's website is opportune-tx.ca
Opportune Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/opportune-therapeutics
Opportune Therapeutics has
2 employees.
View email and phone details for 2
employees at Opportune Therapeutics.
Opportune Therapeutics's industry is
Pharmaceutical Manufacturing
Opportune Therapeutics's top competitors are
Defence Therapeutics,
Sitryx,
Solstar Pharma,
Ebovir Biotechnologie Inc.,
Ovensa Inc.,
Stealth Newco,
Nanobrand,
Akeso Biomedical, Inc.,
Tenvie Therapeutics,
Rna Technologies And Therapeutics.
Opportune Therapeutics's categories are Pharmaceutical Manufacturing
Opportune Therapeutics's founding year is 2018
